190 related articles for article (PubMed ID: 31807856)
21. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
23. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
24. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM; Man F; Lasa JS
Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
[TBL] [Abstract][Full Text] [Related]
25. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
[TBL] [Abstract][Full Text] [Related]
26. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
[TBL] [Abstract][Full Text] [Related]
27. Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials.
Saps M; van Tilburg MA; Lavigne JV; Miranda A; Benninga MA; Taminiau JA; Di Lorenzo C
Neurogastroenterol Motil; 2016 Nov; 28(11):1619-1631. PubMed ID: 27477090
[TBL] [Abstract][Full Text] [Related]
28. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
29. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
30. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
31. Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.
Ida M; Nishida A; Akiho H; Nakashima Y; Matsueda K; Fukudo S
Biopsychosoc Med; 2017; 11():8. PubMed ID: 28331539
[TBL] [Abstract][Full Text] [Related]
32. A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome.
Berry SK; Berry R; Recker D; Botbyl J; Pun L; Chey WD
Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3152-3159.e2. PubMed ID: 37391055
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study.
Brenner DM; Sayuk GS; Gutman CR; Jo E; Elmes SJR; Liu LWC; Cash BD
Am J Gastroenterol; 2019 Sep; 114(9):1502-1511. PubMed ID: 31356229
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review.
Pratt C; Campbell MD
Probiotics Antimicrob Proteins; 2020 Sep; 12(3):834-839. PubMed ID: 31741311
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of New
Oh JH; Jang YS; Kang D; Chang DK; Min YW
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
[TBL] [Abstract][Full Text] [Related]
36. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
[TBL] [Abstract][Full Text] [Related]
37. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
Fukudo S; Ida M; Akiho H; Nakashima Y; Matsueda K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):953-9.e4. PubMed ID: 24315882
[TBL] [Abstract][Full Text] [Related]
38. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
39. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
40. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS.
Tack J; Schumacher K; Tonini G; Scartoni S; Capriati A; Maggi CA;
Gut; 2017 Aug; 66(8):1403-1413. PubMed ID: 27196574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
